NEVVI Medicare utilization intelligence

← back

LOPEZ, JAMESM.D. NPI 1699206946 Clinician

Internal Medicine · SPRINGDALE, AR

Specialty Internal Medicine — from billed Medicare claims
Trained LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN SHREVEPORT — medical school, self-reported to CMS
In practice about 9 years since medical school (class of 2017, self-reported to CMS)
Location SPRINGDALE, AR · NPPES registered location
Active in data Billed Medicare 2020–2024 (3 years)
Scale 56 codes billed · 26,539 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20202026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-07

Year: 2024 · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml premiumpremium premiumpremium
J1071 Injection, testosterone cypionate, 1 mg premiumpremium premiumpremium
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J1437 Injection, ferric derisomaltose, 10 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J2405 Injection, ondansetron hydrochloride, per 1 mg premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
80053 Blood test, comprehensive group of blood chemicals premiumpremium premiumpremium
83615 Lactate dehydrogenase (enzyme) level premiumpremium premiumpremium
83735 Magnesium level premiumpremium premiumpremium
84100 Phosphate level premiumpremium premiumpremium
84550 Uric acid level, blood premiumpremium premiumpremium
82248 Bilirubin level, direct premiumpremium premiumpremium
A9573 Injection, gadopiclenol, 1 ml premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
82728 Ferritin (blood protein) level premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
83540 Iron level premiumpremium premiumpremium
83550 Iron binding capacity premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
71260 Ct scan of chest with contrast premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
74178 Ct scan of abdomen and pelvis before and after contrast premiumpremium premiumpremium
83521 Measurement of immunoglobulin light chains premiumpremium premiumpremium
78815 Nuclear medicine study from skull base to mid-thigh with ct scan premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
96360 Infusion into a vein for hydration, 31-60 minutes premiumpremium premiumpremium
J7030 Infusion, normal saline solution , 1000 cc premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
82607 Cyanocobalamin (vitamin b-12) level premiumpremium premiumpremium
82746 Folic acid level, serum premiumpremium premiumpremium
84443 Blood test, thyroid stimulating hormone (tsh) premiumpremium premiumpremium
84153 Psa (prostate specific antigen) measurement, total premiumpremium premiumpremium
J3490 Unclassified drugs premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
82378 Carcinoembryonic antigen (cea) protein level premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
70491 Ct scan of soft tissue of neck with contrast premiumpremium premiumpremium
85045 Red blood count, automated test premiumpremium premiumpremium
70553 Mri scan of brain before and after contrast premiumpremium premiumpremium
82533 Cortisol (hormone) measurement, total premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.